Cargando…

Prognostic Impact of PD-L1 Expression in Malignant Salivary Gland Tumors as Assessed by Established Scoring Criteria: Tumor Proportion Score (TPS), Combined Positivity Score (CPS), and Immune Cell (IC) Infiltrate

Background: Malignant neoplasms of the salivary glands are rare, and therapeutic options are limited. Results from recently published studies indicate a possible use for checkpoint inhibition in a subset of patients, but there are no established criteria for programme cell death ligand 1 (PD-L1) sco...

Descripción completa

Detalles Bibliográficos
Autores principales:	Witte, Hanno M., Gebauer, Niklas, Lappöhn, Daniela, Umathum, Vincent G., Riecke, Armin, Arndt, Annette, Steinestel, Konrad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226358/ https://www.ncbi.nlm.nih.gov/pubmed/32260165 http://dx.doi.org/10.3390/cancers12040873

Ejemplares similares

The Glasgow Prognostic Score Predicts Survival Outcomes in Neuroendocrine Neoplasms of the Gastro–Entero–Pancreatic (GEP-NEN) System
por: Gebauer, Niklas, et al.
Publicado: (2022)

The expression of the adenosine pathway markers CD39 and CD73 in salivary gland carcinomas harbors the potential for novel immune checkpoint inhibition
por: Bauer, Arthur, et al.
Publicado: (2022)

The Glasgow Prognostic Score at Diagnosis Is a Predictor of Clinical Outcome in Patients with Multiple Myeloma Undergoing Autologous Haematopoietic Stem Cell Transplantation
por: Witte, Hanno M., et al.
Publicado: (2020)

Prognostic impact of nutritional and inflammation-based risk scores in follicular lymphoma in the era of anti-CD20 targeted treatment strategies
por: Gebauer, Niklas, et al.
Publicado: (2021)

Clinical, Serological, and Histopathological Similarities Between Severe COVID-19 and Acute Exacerbation of Connective Tissue Disease-Associated Interstitial Lung Disease (CTD-ILD)
por: Gagiannis, Daniel, et al.
Publicado: (2020)

Predictive Value of Combined Positive Score and Tumor Proportion Score for Immunotherapy Response in Advanced NSCLC
por: Ulas, Ezgi B., et al.
Publicado: (2023)

Pembrolizumab as a monotherapy or in combination with platinum-based chemotherapy in advanced non-small cell lung cancer with PD-L1 tumor proportion score (TPS) ≥50%: real-world data
por: Dudnik, Elizabeth, et al.
Publicado: (2021)

Reliability of programmed death ligand 1 (PD-L1) tumor proportion score (TPS) on cytological smears in advanced non-small cell lung cancer: a prospective validation study
por: Ricci, Costantino, et al.
Publicado: (2020)

Deep Semi Supervised Generative Learning for Automated Tumor Proportion Scoring on NSCLC Tissue Needle Biopsies
por: Kapil, Ansh, et al.
Publicado: (2018)

Reproducibility in PD-L1 Immunohistochemistry Quantification through the Tumor Proportion Score and the Combined Positive Score: Could Dual Immunostaining Help Pathologists?
por: Mercier, Anaïs, et al.
Publicado: (2023)

Prediction of patients with a tumor proportion score > 50% who do not respond to first-line monotherapy with pembrolizumab
por: Morita, Mitsunori, et al.
Publicado: (2020)

The ADRENAL score: A comprehensive scoring system for standardized evaluation of adrenal tumor
por: Zhou, Xiaochen, et al.
Publicado: (2022)

Baseline-adjusted proportional odds models for the quantification of treatment effects in trials with ordinal sum score outcomes
por: Buri, Muriel, et al.
Publicado: (2020)

Association of PD‐L1 tumor proportion score ≥20% with early resistance to osimertinib in patients with EGFR ‐mutated NSCLC
por: Hamakawa, Yusuke, et al.
Publicado: (2023)

Proportional Distribution of Patient Satisfaction Scores by Clinical Service: The PRIME Model
por: Leonard, Michael S, et al.
Publicado: (2015)

Correction to: Baseline-adjusted proportional odds models for the quantification of treatment effects in trials with ordinal sum score outcomes
por: Buri, Muriel, et al.
Publicado: (2020)

Post-anesthetic CPS and EQUUS-FAP scores in surgical and non-surgical equine patients: an observational study
por: Reed, Rachel Anne, et al.
Publicado: (2023)

Serum Inflammation-based Scores in Endocrine Tumors
por: Marques, Pedro, et al.
Publicado: (2021)

Efficacy and Safety of Pembrolizumab in Patients with Refractory Advanced Biliary Tract Cancer: Tumor Proportion Score as a Potential Biomarker for Response
por: Kang, Junho, et al.
Publicado: (2020)

Efficacy of immune checkpoint inhibitors according to PD‐L1 tumor proportion scores in non‐small cell lung cancer
por: Park, Seongho, et al.
Publicado: (2019)

Automated tumor proportion score analysis for PD-L1 (22C3) expression in lung squamous cell carcinoma
por: Liu, Jingxin, et al.
Publicado: (2021)

Clarification of Triage Scoring Criteria
Publicado: (2021)

Continuous Metabolic Syndrome Scores for Children Using Salivary Biomarkers
por: Shi, Ping, et al.
Publicado: (2015)

An approach to scoring cursorial limb proportions in carnivorous dinosaurs and an attempt to account for allometry
por: Persons IV, W. Scott, et al.
Publicado: (2016)

Trend-constrained corrected score for proportional hazards model with covariate measurement error
por: Zhu, Ming, et al.
Publicado: (2015)

From the Spinopelvic Parameters to Global Alignment and Proportion Scores in Adult Spinal Deformity
por: Cho, Yongjae, et al.
Publicado: (2023)

Automated tumor proportion scoring for PD-L1 expression based on multistage ensemble strategy in non-small cell lung cancer
por: Pan, Boju, et al.
Publicado: (2021)

The TPS begins to shine
Publicado: (2015)

Z Scores, Standard Scores, and Composite Test Scores Explained
por: Andrade, Chittaranjan
Publicado: (2021)

Clinical prognostic scores for patients with thymic epithelial tumors
por: Veraar, Cecilia, et al.
Publicado: (2019)

The Significance of Tumor Microenvironment Score for Breast Cancer Patients
por: Tian, Yuan, et al.
Publicado: (2022)

A universal molecular prognostic score for gastrointestinal tumors
por: Shimizu, Hideyuki, et al.
Publicado: (2021)

Sleep scoring moving from visual scoring towards automated scoring
por: Penzel, Thomas
Publicado: (2022)

From Soranus score to Apgar score
por: Razaz, Neda
Publicado: (2020)

Comparison of qSOFA Score, SIRS Criteria, and SOFA Score as predictors of mortality in patients with sepsis
por: Khan, A M, et al.
Publicado: (2022)

Modified Global Alignment and Proportion Scoring With Body Mass Index and Bone Mineral Density Analysis in Global Alignment and Proportion Score of Each 3 Categories for Predicting Mechanical Complications After Adult Spinal Deformity Surgery
por: Noh, Sung Hyun, et al.
Publicado: (2021)

Scoring the tumor-stroma ratio in colon cancer: procedure and recommendations
por: van Pelt, G. W., et al.
Publicado: (2018)

Histological scores and tumor size on stage II in adrenocortical carcinomas
por: Oliveira, Rui Caetano, et al.
Publicado: (2021)

Heterogeneous distribution pattern of CD3+ tumor-infiltrated lymphocytes (TILs) and high combined positive score (CPS) favored the prognosis of resected early stage small-cell lung cancer
por: Zhu, Liang, et al.
Publicado: (2023)

Optimization of the Revised Tokuhashi Scoring System: New Prognostic Criteria for Metastatic Spinal Tumor in Surgical Cases
por: Iinuma, Masahiro, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1d3l9b1o20rv852ea6ga77pd78